Helicobacter pylori is well established as a causative agent for gastritis, peptic ulcer, and
gastric cancer. Armed with various inimitable virulence factors, this Gram-negative bacterium …

Simple Summary Gastric cancer is still one of the leading causes of death caused by cancer
in developing countries. The emerging role of immunotherapy in cancer treatment has led to …

Background Accumulating evidence shows that Helicobacter pylori protects against some
metabolic and immunological diseases in which the development of these diseases …

Lactobacillus fermentum has been used in industrial processes and food fermentation for a
long time. Because it is of human origin, non-pathogenic, has high resistance to passing …

Signals modulating the production of Mycobacterium tuberculosis (Mtb) virulence factors
essential for establishing long-term persistent infection are unknown. The WhiB3 redox …

Background Expression of cluster of differentiation (CD) antigens changes according to
disease status and inflammation. Profiles of CD antigens expression in gastric cancer …

Background Interferon-γ (IFN-γ) or interleukin-4 (IL-4) drives widely different transcriptional
programs in macrophages. However, how IFN-γ and IL-4 alter expression of histone …

Podoplanin (Pdpn) is a mucin-type transmembrane protein that has been implicated in
multiple physiological settings including lymphangiogenesis, platelet aggregation, and …

Infection with H. pylori induces chronic gastric inflammation, progressing to peptic ulcer and
stomach adenocarcinoma. Macrophages function as innate immune cells and play a vital …

Helicobacter pylori (H. pylori) is a worldwide spread bacterium, co-evolving with humans for
at least 100 000 years. Despite the uncertainty about the mode of H. pylori transmission, the …